This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during October 2024 (epidemiological weeks 40-44). The data is dependent on submission of samples by clinicians and therefore may not be...
In this report we present laboratory-based data for all GIT molecular panels requested for patients at PathCare laboratories for the last two quarters (March to August 2024). We have included graphs and data for bacterial, viral and parasitic causes of diarrhoea....
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during September 2024 (epidemiological weeks 36-39). The data is dependent on submission of samples by clinicians and therefore may not be...
Membranous Nephropathy (MN) is among the most common causes of nephrotic syndrome in adults without diabetes. If left untreated, it can progress to kidney failure. Depending on the absence or presence of associated conditions, MN is traditionally classified as primary...
Testing for PIK3CA and AKT1 mutations in tumors is important for several reasons, especially in the context of personalized medicine and targeted cancer therapy. PIK3CA and AKT1 are genes involved in the PI3K/AKT/mTOR signaling pathway, which plays a crucial role in...
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during August 2024 (epidemiological weeks 32-35). The data is dependent on submission of samples by clinicians and therefore may not be...
Autoimmune bullous skin disease (AIBD) is a group of blistering skin disorders caused by autoantibodies directed against various structural proteins of the skin. The main clinical features are blisters and bullae in the skin and mucous membranes, progressing to...
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during July 2024 (epidemiological weeks 27-31). The data is dependent on submission of samples by clinicians and therefore may not be...
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during June 2024 (epidemiological weeks 23-26). The data is dependent on submission of samples by clinicians and therefore may not be...
Since May 2022, more than 97 000 cases of mpox have been reported globally from 117 countries, with 186 deaths (as of 31 May 2024). Between June and September of 2022, five cases of mpox were reported in South Africa, with no fatalities. All of these cases reported...